Part 3 Monitoring for indicative dose and analytical performance characteristics

England and Wales

1. 6Paragraph 6
2. 7Paragraph 7
3. 8Screening for certain radionuclides, or screening for an individual radionuclide
4. 9Paragraph 9
5. 10Screening strategies for gross alpha activity and gross beta activity
6. 11Paragraph 11
7. 12Paragraph 12
8. 13Calculation of the indicative dose
9. 14Paragraph 14
10. 15Performance characteristics and methods of analysis